Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2021-06-14 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
ADAPT Conduit Proof of Concept Study finds no Calcification 2 pages 104.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 14 June 2021 from Anteris Technologies Ltd. It reports the successful completion of a Proof of Concept animal study related to their ADAPT treated conduits, highlighting scientific and clinical results. The content is a corporate announcement about a study outcome and future plans, not a financial report, regulatory filing, or management discussion. It does not contain financial statements, voting results, or executive changes. The document length is 3904 characters, which is relatively short and typical for an announcement. There is no indication that this is a full report or detailed presentation, nor is it a certification or legal update. Therefore, the best fitting category is a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories.
2021-06-14 English
Notice of Annual General Meeting/Proxy Form 33 pages 1.1MB
AGM Information Classification · 95% confidence The document is titled as a Notice of Annual General Meeting (AGM) for Anteris Technologies Ltd, dated 15 June 2021, with the meeting scheduled for 15 July 2021. It includes the agenda for the AGM, such as consideration of the Annual Report, adoption of the Remuneration Report, re-election of a director, approval of share issuance facilities, adoption of a new constitution, and ratification of prior share issues. The document is a formal notice and explanatory memorandum sent to shareholders to inform them about the AGM and the resolutions to be voted on. It does not contain the actual Annual Report, financial statements, or detailed financial data but rather serves as the meeting notice and related explanatory materials. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including notices and explanatory memoranda.
2021-06-14 English
Change of Director's Interest Notice 3 pages 269.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's acquisition of shares and options, including dates, quantities, and values. This type of document is a formal notification of a director's personal share transactions, which aligns with the definition of 'Director's Dealing' filings. The document is not a financial report, earnings release, or management information, but specifically a report of insider transactions by a company director. Therefore, the correct classification is DIRS.
2021-06-09 English
Research & Development Tax Refund 2 pages 173.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 3 June 2021 regarding the receipt of a $1.49 million Research and Development Tax Incentive refund for the year ended 31 December 2020. It discusses the repayment of a short-term facility related to the R&D tax incentive and provides background on the company's R&D activities. The document is short (2828 characters) and serves as a financial update related to government incentives and financing arrangements. It does not contain financial statements, detailed financial performance data, or comprehensive management discussion. It is not a full annual or interim report, nor is it a regulatory certification or legal proceeding. The content fits best under Capital/Financing Update (CAP) as it relates to financing activities and receipt of funds impacting the company's capital structure.
2021-06-02 English
Becoming a substantial holder 2 pages 218.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 filed under the Corporations Act 2001 Section 671B, titled 'Notice of initial substantial holder.' It details the substantial shareholding of Mercer Street Global Opportunity Fund, LLC in Anteris Technologies Ltd, including voting power, relevant interests, registered holders, consideration paid, and associates. This form is a regulatory notification of a major shareholding crossing a threshold, which aligns with the definition of Major Shareholding Notification (MRQ). The document is not a financial report, management information, or any other type of filing but specifically a notification of substantial shareholding as required by law.
2021-06-01 English
Appendix 2A 17 pages 316.6KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 2A' and is an 'Application for quotation of securities' submitted to the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities to be quoted, references to ASX Listing Rules, and dates related to securities issuance. This type of document is a formal application for listing new securities on the exchange, which is a regulatory announcement related to capital markets activities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The document fits the category of a regulatory filing related to capital markets compliance and disclosure requirements but does not fit into more specific categories like Capital/Financing Update or Share Issue/Capital Change because it is specifically an application for quotation of securities, which is a regulatory announcement. Therefore, the best classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a full regulatory announcement, not a brief notice or report publication announcement.
2021-05-31 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.